Mikhail Shchepinov

Mikhail Shchepinov


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2015 in Journal of Neurochemistry
Verified
Journal Article
Open access
PDF file
Plamena R. AngelovaPlamena R. Angelova
Plamena R. Angelova
MHMathew H. Horrocks
Mathew H. Horrocks
DKDavid Klenerman
David Klenerman
SGSonia Gandhi
Sonia Gandhi
AAANDREY Abramov
ANDREY Abramov
MSMikhail Shchepinov
Mikhail Shchepinov
Parkinson's disease is the second most common neurodegenerative disease and its pathogenesis is closely associated with oxidative stress. Deposition of aggregated α‐synuclein (α‐Syn) occurs in familial and sporadic forms of Parkinson's disease. Here, we studied the effect of oligomeric α‐Syn on one of the major markers of oxidative stress, lipid peroxidation, in primary co‐cultures of neurons and astrocytes. We found that oligomeric but not monomeric α‐Syn significantly increases the rate of production of reactive oxygen species, subsequently inducing lipid peroxidation in both neurons and astrocytes. Pre‐incubation of cells with isotope‐reinforced polyunsaturated fatty acids (D‐PUFAs) completely prevented the effect of oligomeric α‐Syn on lipid peroxidation. Inhibition of lipid peroxidation with D‐PUFAs further protected cells from cell death induced by oligomeric α‐Syn. Thus, lipid peroxidation induced by misfolding of α‐Syn may play an important role in the cellular mechanism of neuronal cell loss in Parkinson's disease. image We have found that aggregated α‐synuclein‐induced production of reactive oxygen species (ROS) that subsequently stimulates lipid peroxidation and cell death in neurons and astrocytes. Specific inhibition of lipid peroxidation by incubation with reinforced polyunsaturated fatty acids (D‐PUFAs) completely prevented the effect of α‐synuclein on lipid peroxidation and cell death.

1 August 2012 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
SHShauna Hill
Shauna Hill
CLConnor R. Lamberson
Connor R. Lamberson
LXLibin Xu
Libin Xu
RTRandy To
Randy To
HTHui S. Tsui
Hui S. Tsui
MSMikhail Shchepinov
Mikhail Shchepinov

6 April 2018 in Movement Disorders
Verified
Journal Article
Closed access
PDF file
TZTheresa Zesiewicz
Theresa Zesiewicz
FHFrederic Heerinckx
Frederic Heerinckx
RJRobert De Jager
Robert De Jager
OOOmid Omidvar
Omid Omidvar
MKMarcus Kilpatrick
Marcus Kilpatrick
MSMikhail Shchepinov
Mikhail Shchepinov

1 April 2020 in Trends in Pharmacological Sciences
Verified
Journal Article
Closed access
MSMikhail Shchepinov
Mikhail Shchepinov

1 November 2011 in Toxicology Letters
Verified
Journal Article
Closed access
MSMikhail Shchepinov
Mikhail Shchepinov
VCVivian P. Chou
Vivian P. Chou
EPErik Pollock
Erik Pollock
JLJ. William Langston
J. William Langston
CCCharles R. Cantor
Charles R. Cantor
AMAmy B. Manning-Boğ
Amy B. Manning-Boğ

1 January 2011 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
SHShauna Hill
Shauna Hill
KHKathleen Hirano
Kathleen Hirano
VSVadim Shmanai
Vadim Shmanai
BMBeth N. Marbois
Beth N. Marbois
DVDragoslav Vidovic
Dragoslav Vidovic
MSMikhail Shchepinov
Mikhail Shchepinov